Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administration
- 1 April 1979
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 28 (7), 1221-1225
- https://doi.org/10.1016/0006-2952(79)90333-2
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- DOES O-METHYL-DOPA PLAY A ROLE IN LEVODOPA-INDUCED DYSKINESIAS?Acta Neurologica Scandinavica, 2009
- Considerations in the management of parkinsonismNeurology, 1978
- The Clinical Picture and Plasma Levodopa Metabolite Profile of Parkinsonian NonrespondersArchives of Neurology, 1977
- SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASEThe Lancet, 1977
- Study of deterioration in long-term treatment of parkinsonism with L-Dopa plus decarboxylase inhibitorJournal of Neural Transmission, 1976
- “On‐off” phenomenon with levodopa therapy in parkinsonismNeurology, 1974
- Potentiation of the l-Dopa effect in man by the use of catechol-O-methyltransferase inhibitorsJournal of the Neurological Sciences, 1971
- Dopa and 3-O-methyldopa in cerebrospinal fluid of parkinsonism patients during treatment with oral l-dopaClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- Convulsant Action of PolyphenolsNature, 1968
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967